We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biogeneric Approval Pathway Could Save Billions, CBO Says
Biogeneric Approval Pathway Could Save Billions, CBO Says
December 31, 2008
Government healthcare plans such as Medicare and Medicaid could save more than $10 billion over about a decade under a modified approval pathway for follow-on biologics (FOBs), according to a Congressional Budget Office (CBO) report.